title: Evolution of CCR5 use before and during coreceptor switching.
abstract: The envelope gene (env) of human immunodeficiency virus type 1 (HIV-1) undergoes rapid divergence from the transmitted sequence and increasing diversification during the prolonged course of chronic infection in humans. In about half of infected individuals or more, env evolution leads to expansion of the use of entry coreceptor from CCR5 alone to CCR5 and CXCR4. The stochastic nature of this coreceptor switch is not well explained by host selective forces that should be relatively constant between infected individuals. Moreover, differences in the incidence of coreceptor switching among different HIV-1 subtypes suggest that properties of the evolving virus population drive the switch. We evaluated the functional properties of sequential env clones from a patient with evidence of coreceptor switching at 5.67 years of infection. We found an abrupt decline in the ability of viruses to use CCR5 for entry at this time, manifested by a 1- to 2-log increase in susceptibility to CCR5 inhibitors and a reduced ability to infect cell lines with low CCR5 expression. There was an abnormally rapid 5.4% divergence in env sequences from 4.10 to 5.76 years of infection, with the V3 and V4/V5 regions showing the greatest divergence and evidence of positive selection. These observations suggest that a decline in the fitness of R5 virus populations may be one driving force that permits the emergence of R5X4 variants.
authors.affiliation: Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
authors.forename: Mia
authors.initials: M
authors.lastname: Coetzer
authors.forename: Rebecca
authors.initials: R
authors.lastname: Nedellec
authors.forename: Janelle
authors.initials: J
authors.lastname: Salkowitz
authors.forename: Sherry
authors.initials: S
authors.lastname: McLaughlin
authors.forename: Yi
authors.initials: Y
authors.lastname: Liu
authors.forename: Laura
authors.initials: L
authors.lastname: Heath
authors.forename: James I
authors.initials: JI
authors.lastname: Mullins
authors.forename: Donald E
authors.initials: DE
authors.lastname: Mosier
mesh_terms: D065100:CCR5 Receptor Antagonists; D006801:Humans; D019713:Receptors, CCR5 / Q000032:analysis / Q000737:chemistry / Q000502:physiology*; D019718:Receptors, CXCR4 / Q000502:physiology*; D054299:env Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000502:physiology
chemical_list: D065100:CCR5 Receptor Antagonists; C527276:CXCR4 protein, human; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D054299:env Gene Products, Human Immunodeficiency Virus